Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2430 to 2479 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2430\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EPN1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
epsin 1; eh domain-binding mitotic phosphoprotein. [source:refseq;acc:nm\_013333]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.873\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.644\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00354\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2431\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSMA2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
proteasome subunit alpha type 2 (ec 3.4.25.1) (proteasome component c3) (macropain subunit c3) (multicatalytic endopeptidase complex subunit c3). [source:swissprot;acc:p25787]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.048\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00352\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2432\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSMD6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 6 (26s proteasome regulatory subunit s10) (p42a) (proteasome regulatory particle subunit p44s10). [source:swissprot;acc:q15008]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.807\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.556\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00347\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2433\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EEF1AL3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
elongation factor 1-alpha 1 (ef-1-alpha-1) (elongation factor 1 a-1) (eef1a-1) (elongation factor tu) (ef-tu). [source:swissprot;acc:p04720]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.366\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.117\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00346\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2434\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MTHFR\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
methylenetetrahydrofolate reductase (ec 1.5.1.20). [source:swissprot;acc:p42898]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.021\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.286\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2435\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZNF259\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc-finger protein zpr1 (zinc finger protein 259). [source:swissprot;acc:o75312]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
217.366\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
218.117\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2436\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EEF1A2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
elongation factor 1-alpha 2 (ef-1-alpha-2) (elongation factor 1 a-2) (eef1a-2) (statin s1). [source:swissprot;acc:q05639]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2437\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GUK1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
guanylate kinase (ec 2.7.4.8) (gmp kinase). [source:swissprot;acc:q16774]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.361\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
220.116\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00344\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2438\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSMA4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
proteasome subunit alpha type 4 (ec 3.4.25.1) (proteasome component c9) (macropain subunit c9) (multicatalytic endopeptidase complex subunit c9) (proteasome subunit l). [source:swissprot;acc:p25789]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.049\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.323\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0034\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2439\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
YWHAB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
14-3-3 protein beta/alpha (protein kinase c inhibitor protein-1) (kcip-1) (protein 1054). [source:swissprot;acc:p31946]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.681\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
221.425\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00337\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2440\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSMD3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 3 (26s proteasome regulatory subunit s3) (proteasome subunit p58). [source:swissprot;acc:o43242]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.645\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.376\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00336\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2441\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ETFA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
electron transfer flavoprotein alpha-subunit, mitochondrial precursor (alpha-etf). [source:swissprot;acc:p13804]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
180.137\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
180.732\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0033\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2442\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TAF6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription initiation factor tfiid 70 kda subunit (tafii-70) (tafii-80) (tafii80). [source:swissprot;acc:p49848]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.419\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.748\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00329\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2443\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UBE2I\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ubiquitin-like protein sumo-1 conjugating enzyme (ec 6.3.2.19) (sumo- 1-protein ligase) (ubiquitin carrier protein) (ubiquitin-conjugating enzyme ubce2a) (p18). [source:swissprot;acc:p50550]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.073\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.364\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00328\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2444\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZBTB20\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein 288 (dendritic-derived btb/poz zinc finger protein). [source:swissprot;acc:q9hc78]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.086\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.753\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00324\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2445\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZBTB7B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
kruppel-related zinc finger protein hckrox. [source:refseq;acc:nm\_015872]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.088\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.756\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2446\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EPHX1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
epoxide hydrolase 1 (ec 3.3.2.3) (microsomal epoxide hydrolase) (epoxide hydratase). [source:swissprot;acc:p07099]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
182.272\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
181.683\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2447\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PEX7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
peroxisomal targeting signal 2 receptor (pts2 receptor) (peroxin-7). [source:swissprot;acc:o00628]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.084\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.752\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2448\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glycine dehydrogenase [decarboxylating], mitochondrial precursor (ec 1.4.4.2) (glycine decarboxylase) (glycine cleavage system p- protein). [source:swissprot;acc:p23378]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.446\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.766\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00321\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2449\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phosphatidate cytidylyltransferase 2 (ec 2.7.7.41) (cdp-diglyceride synthetase 2) (cdp-diglyceride pyrophosphorylase 2) (cdp- diacylglycerol synthase 2) (cds 2) (ctp:phosphatidate cytidylyltransferase 2) (cdp-dag synthase 2) (cdp-dg synthetase 2). [source:swissprot;acc:o95674]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.717\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.371\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00319\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2450\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSMB6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
proteasome subunit beta type 6 precursor (ec 3.4.25.1) (proteasome delta chain) (macropain delta chain) (multicatalytic endopeptidase complex delta chain) (proteasome subunit y). [source:swissprot;acc:p28072]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00316\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2451\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SCAMP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 2. [source:swissprot;acc:o15127]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
204.688\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
205.333\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00315\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2452\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SCAMP3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 3. [source:swissprot;acc:o14828]\vspace{3pt}}&&&\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2453\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SCAMP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 1. [source:swissprot;acc:o15126]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
205.332\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2454\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC13A4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
solute carrier family 13, member 4 (na+/sulfate cotransporter sut-1). [source:swissprot;acc:q9ukg4]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
204.683\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
205.326\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00314\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2455\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC13A3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
solute carrier family 13, member 3 (sodium-dependent high-affinity dicarboxylate transporter 2) (na(+)/dicarboxylate cotransporter 3) (nadc-3) (hnadc3). [source:swissprot;acc:q8wwt9]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2456\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC13A1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
solute carrier family 13, member 1 (renal sodium/sulfate cotransporter) (na(+)/sulfate cotransporter) (hnasi-1). [source:swissprot;acc:q9bzw2]\vspace{3pt}}&&&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2457\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NSF\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
vesicle-fusing atpase (ec 3.6.4.6) (vesicular-fusion protein nsf) (n- ethylmaleimide sensitive fusion protein) (nem-sensitive fusion protein). [source:swissprot;acc:p46459]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.588\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.92\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2458\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC13A2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
solute carrier family 13, member 2 (renal sodium/dicarboxylate cotransporter) (na(+)/dicarboxylate cotransporter 1) (nadc-1). [source:swissprot;acc:q13183]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.683\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.326\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2459\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phosphatidate cytidylyltransferase 1 (ec 2.7.7.41) (cdp-diglyceride synthetase 1) (cdp-diglyceride pyrophosphorylase 1) (cdp- diacylglycerol synthase 1) (cds 1) (ctp:phosphatidate cytidylyltransferase 1) (cdp-dag synthase 1) (cdp-dg synthetase 1). [source:swissprot;acc:q92903]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.653\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.286\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00309\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2460\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pepsin a precursor (ec 3.4.23.1). [source:swissprot;acc:p00790]\vspace{3pt}}&\multirow{12}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
235.812\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
235.088\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00308\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2461\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC20A2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
solute carrier family 20 (phosphate transporter), member 2; glvr-2; pit-2; gibbon ape leukemia virus receptor 2; murine leukemia virus, amphotropic; receptor. [source:refseq;acc:nm\_006749]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2462\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FDPS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
farnesyl pyrophosphate synthetase (fpp synthetase) (fps) (farnesyl diphosphate synthetase) [includes: dimethylallyltransferase (ec 2.5.1.1); geranyltranstransferase (ec 2.5.1.10)]. [source:swissprot;acc:p14324]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2463\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PCDH15\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protocadherin 15 precursor. [source:swissprot;acc:q96qu1]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2464\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC20A1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
solute carrier family 20 (phosphate transporter), member 1; glvr-1; pit-1; gibbon ape leukemia virus receptor 1. [source:refseq;acc:nm\_005415]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2465\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LMBR1L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lipocalin-interacting membrane receptor. [source:refseq;acc:nm\_018113]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2466\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GLI1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein gli1 (glioma-associated oncogene) (oncogene gli). [source:swissprot;acc:p08151]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2467\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SUFU\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
suppressor of fused. [source:refseq;acc:nm\_016169]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2468\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GLI3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein gli3. [source:swissprot;acc:p10071]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2469\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LMBR1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
limb region 1 protein; limb region 1. [source:refseq;acc:nm\_022458]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2470\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PGC\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
gastricsin precursor (ec 3.4.23.3) (pepsinogen c). [source:swissprot;acc:p20142]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2471\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GLI2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein gli2 (tax helper protein). [source:swissprot;acc:p10070]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2472\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TNS3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tumor endothelial marker 6; thyroid specific ptb domain protein; tensin 3. [source:refseq;acc:nm\_022748]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.218\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.564\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00301\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2473\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MAPK8IP3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
c-jun-amino-terminal kinase interacting protein 3 (jnk-interacting protein 3) (jip-3) (jnk map kinase scaffold protein 3) (mitogen- activated protein kinase 8-interacting protein 3). [source:swissprot;acc:q9upt6]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.644\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.991\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.003\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2474\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSMC3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
26s protease regulatory subunit 6a (tat-binding protein 1) (tbp-1) (proteasome subunit p50). [source:swissprot;acc:p17980]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.285\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00298\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2475\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TENC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
c1 domain-containing phosphatase and tensin-like protein isoform 2; putative protein tyrosine phosphatase; c1 domain-containing phosphatase and tensin-like protein; tensin 2. [source:refseq;acc:nm\_015319]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.219\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
217.571\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2476\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
XYLB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
xylulokinase homolog; xylulokinase (h. influenzae) homolog. [source:refseq;acc:nm\_005108]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.205\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.577\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2477\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MRPL30\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l30 isoform a. [source:refseq;acc:nm\_145212]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
216.177\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
216.801\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.00289\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
2478\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSMC6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
26s protease regulatory subunit s10b (proteasome subunit p42) (p44) (conserved atpase domain protein 44) (cadp44). [source:swissprot;acc:q92524]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2479\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRR5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rho-gtpase-activating protein 8. [source:swissprot;acc:q9nsg0]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.093\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.72\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.00287\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/